What Challenges Exist in Accessing Essential Cancer Medicines?
Several challenges impede access to essential cancer medicines:
High Costs: Many cancer drugs are prohibitively expensive, making them unaffordable for individuals and healthcare systems in low-income countries. Supply Chain Issues: Poor infrastructure and logistical challenges can lead to interruptions in the supply of essential medicines. Regulatory Barriers: The process of approving new drugs can be lengthy and complex, delaying the availability of essential medicines. Lack of Awareness: Inadequate knowledge about the importance of essential medicines among healthcare providers and patients can also limit access.
